UncategorizedKlotho Neurosciences signs LOI to acquire Turn Biotechnologies assets – Longevity.Technology Empower Meds / October 3, 2025
UncategorizedMolecule shows skin longevity potential in sun aging study Empower Meds / October 2, 2025
UncategorizedAlnylam begins global Phase 3 trial dosing of zilebesiran – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedBiomed reports positive Phase 2 results for new oral obesity drug NA-931 – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedRokit America to scale operations in the Americas as regenerative hub – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedC2N files FDA submission for Alzheimer’s blood-test – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedMyrtelle releases interim data from gene therapy trial for Canavan disease – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedOmada Health rolls out Meal Map, AI tool to shift focus from calories to nutrient density – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedEmagene Life inks global partnership with IFM – Longevity.Technology Empower Meds / October 2, 2025
